Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin sensitiser drugs.

E Murphy1, J J Nolan

  • 1Metabolic Research Unit, Department of Endocrinology, St. James's Hospital, Dublin, Ireland. elmurphy@indigo.ie

Expert Opinion on Investigational Drugs
|November 4, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond congenital anomalies, the impact of sodium valproate exposure in utero on long-term health and well-being: A contribution from the ConcePTION project.

Epilepsia·2026
Same author

A five-year retrospective review of Protocol 37 transfers from a model 3 hospital Emergency Department.

Irish medical journal·2026
Same author

Management of anastomotic leak following restorative rectal cancer resection-a multi-centre retrospective audit in Ireland.

Irish journal of medical science·2026
Same author

Digital endoscopic characterisation of significant rectal neoplasia: A video vignette.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2025
Same author

Local excision of rectal neoplasia: a real-world survey of current practices and perspectives.

Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy·2025
Same author

A meta-analysis of the sources of variation in the environmental impacts of different broiler production systems.

British poultry science·2024
Same journal

Advancements in longevity pharmacology research - are we finally seeing clinical progression?

Expert opinion on investigational drugs·2026
Same journal

Consideration of the use of nalbuphine in idiopathic pulmonary fibrosis-associated cough: to cough or not to cough so much?

Expert opinion on investigational drugs·2026
Same journal

Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis.

Expert opinion on investigational drugs·2026
Same journal

Cannabinoid use in adults with sickle cell disease: therapeutic development and clinical insights.

Expert opinion on investigational drugs·2026
Same journal

Odronextamab: a bispecific antibody for follicular lymphoma.

Expert opinion on investigational drugs·2026
Same journal

Evaluating the investigational drug landscape for <i>ESR1</i>-mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer.

Expert opinion on investigational drugs·2026
See all related articles

Insulin resistance, a key defect in Type 2 diabetes, drives metabolic issues and cardiovascular risk. New oral therapies targeting insulin sensitivity show promise for better glucose control and preventing diabetic complications.

Area of Science:

  • Endocrinology
  • Metabolic Syndrome
  • Pharmacology

Background:

  • Insulin resistance is the primary early defect in Type 2 diabetes.
  • It is linked to increased cardiovascular risk and metabolic disturbances like visceral adiposity and hypertension.
  • Existing treatments focus on managing symptoms rather than addressing the root cause.

Purpose of the Study:

  • To evaluate novel oral antidiabetic therapies.
  • To assess the impact of these therapies on insulin sensitivity.
  • To determine the potential of improving insulin sensitivity in managing Type 2 diabetes and its complications.

Main Methods:

  • Investigated new oral antidiabetic agents.
  • Focused on therapies designed to enhance insulin sensitivity.

Related Experiment Videos

  • Examined effects on muscle, adipose tissue, and hepatic insulin sensitivity.

    • Main Results:

    • Targeting insulin sensitivity at key metabolic sites improved glycaemic control.
    • Observed improvements in other features of the insulin resistance syndrome.
    • Demonstrated potential for long-term benefits in disease management.

    Conclusions:

    • Novel oral therapies improving insulin sensitivity represent a promising approach.
    • These treatments offer potential to delay diabetic complications and macrovascular disease.
    • Addressing insulin resistance directly can lead to comprehensive metabolic improvements.